Risks and Benefits of Antipsychotic Drugs in Elderly Patients with Dementia

2008 ◽  
Vol 46 (11) ◽  
pp. 19-23 ◽  
Author(s):  
Robert H. Howland
2020 ◽  
Vol 30 (2) ◽  
pp. 81-86
Author(s):  
Soo Mi Yoon ◽  
Sungwon Lee ◽  
Ji-Eun Chang ◽  
Young Sook Lee ◽  
Kiyon Rhew

2013 ◽  
Vol 28 ◽  
pp. 1
Author(s):  
H. Ben Ammar ◽  
A. Bel Arbi ◽  
L. Robbana ◽  
O. Moula ◽  
A. Bouasker ◽  
...  

2008 ◽  
Vol 8 (8) ◽  
pp. 776-783 ◽  
Author(s):  
Sara Mazzucco ◽  
Andrea Cipriani ◽  
Corrado Barbui ◽  
Salvatore Monaco

2022 ◽  
Vol 14 (1) ◽  
pp. 62-74
Author(s):  
Amber N. Edinoff ◽  
Niroshan Sathivadivel ◽  
Shawn E. McNeil ◽  
Austin I. Ly ◽  
Jaeyeon Kweon ◽  
...  

Pregnant women constitute a vulnerable population, with 25.3% of pregnant women classified as suffering from a psychiatric disorder. Since childbearing age typically aligns with the onset of mental health disorders, it is of utmost importance to consider the effects that antipsychotic drugs have on pregnant women and their developing fetus. However, the induction of pharmacological treatment during pregnancy may pose significant risks to the developing fetus. Antipsychotics are typically introduced when the nonpharmacologic approaches fail to produce desired effects or when the risks outweigh the benefits from continuing without treatment or the risks from exposing the fetus to medication. Early studies of pregnant women with schizophrenia showed an increase in perinatal malformations and deaths among their newborns. Similar to schizophrenia, women with bipolar disorder have an increased risk of relapse in antepartum and postpartum periods. It is known that antipsychotic medications can readily cross the placenta, and exposure to antipsychotic medication during pregnancy is associated with potential teratogenicity. Potential risks associated with antipsychotic use in pregnant women include congenital abnormalities, preterm birth, and metabolic disturbance, which could potentially lead to abnormal fetal growth. The complex decision-making process for treating psychosis in pregnant women must evaluate the risks and benefits of antipsychotic drugs.


2021 ◽  
Vol 12 ◽  
Author(s):  
Mi Yang ◽  
Qiwen Li ◽  
Chunzhi Wang ◽  
Li Li ◽  
Min Xu ◽  
...  

Introduction: Pneumonia is an important cause of death in patients with schizophrenia. It is critical to understand the risk factors of hospital-acquired pneumonia (HAP) and determine prevention strategies to reduce HAP. The aim of this study is to elucidate the risk factors for HAP in the middle-aged and elderly hospitalized patients with schizophrenia.Methods: We retrospectively reviewed the medical records of 2,617 the middle-aged and elderly patients (age ≥ 50) with schizophrenia who were admitted for the first time to a large-scale psychiatric hospital between 2016 and 2020. The factors related to the incidence of HAP in patients were analyzed, including personal characteristics, antipsychotics, and non-antipsychotics.Results: The HAP infection rate of hospitalized the middle-aged and elderly patients with schizophrenia was 7.8%. Chi-square analyses showed that older age, male, and ≥60 days of hospitalization were risk factors for HAP infection (χ2 = 94.272, p < 0.001; χ2 = 22.110, p < 0.001; χ2 = 8.402, p = 0.004). Multivariate logistic regression showed that quetiapine, clozapine, and olanzapine significantly increased the incidence of HAP (OR = 1.56, 95% CI = 1.05–2.32, p = 0.029; OR = 1.81, 95% CI = 1.26–2.60, p = 0.001; OR = 1.68, 95% CI = 1.16–2.42, p = 0.006). Antipsychotic drugs combined with aceglutamide had an effect on HAP (OR = 2.19, 95% CI = 1.38–3.47, p = 0.001).Conclusion: The high HAP infection rate in hospitalized the middle-aged and elderly patients with schizophrenia may be related to the increase of age and the use of antipsychotic drugs. The types and dosages of antipsychotic drugs should be minimized while paying attention to the mental symptoms of patients.


Author(s):  
Tom Declercq ◽  
Mirko Petrovic ◽  
Robert Vander Stichele ◽  
An IM De Sutter ◽  
Mieke L van Driel ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document